Comparative Pharmacology
Head-to-head clinical analysis: CHLOROMYXIN versus CIPRO HC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHLOROMYXIN versus CIPRO HC.
CHLOROMYXIN vs CIPRO HC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chloromyxin is a combination product of chloramphenicol and polymyxin B. Chloramphenicol inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation. Polymyxin B disrupts bacterial cell membrane integrity by interacting with lipopolysaccharides in gram-negative bacteria.
Ciprofloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, preventing DNA replication and transcription; hydrocortisone suppresses inflammation via glucocorticoid receptor activation.
500 mg IV every 6 hours or 1 g IV every 12 hours; infusion over 30 minutes.
Instill 3 drops into the affected ear(s) twice daily (morning and evening) for 7 days.
None Documented
None Documented
CHLOROMYXIN is not a recognized drug. No data available.
Ciprofloxacin: 4-6 hours (prolonged to 6-9 hours in elderly or renal impairment). Hydrocortisone: 1-2 hours.
CHLOROMYXIN is not a recognized drug. No data available.
Ciprofloxacin: ~50-70% excreted renally as unchanged drug, ~15% as metabolites; ~20-30% eliminated via biliary/fecal route. Hydrocortisone: metabolized hepatically, renal excretion of metabolites.
Category C
Category C
Antibiotic
Antibiotic/Corticosteroid Combination (Otic)